Endovascular carotid stenting demonstrates high technical success and acceptable periprocedural risks, supporting its growth as an alternative to vascular surgery for high-risk patients.
Answers are grounded in this paper and cite their sources.
Supports carotid stenting feasibility in high-risk patients; leaves open randomized comparisons to endarterectomy.
Our purpose was to review the current status of carotid artery stent placement throughout the world. Surveys were sent to major interventional centers in Europe, North and South America, and Asia. Information from peer-reviewed journals was also included and supplemented the survey. The survey asked various questions regarding the patients enrolled, procedure techniques, and results of carotid stenting, including complications and restenosis. Of the centers which were sent surveys, 24 responded. The total number of endovascular carotid stent procedures that have been performed worldwide to date included 2,048 cases, with a technical success of 98.6%. Complications that occurred during carotid stent placement or within a 30-day period following placement were recorded. Overall, there were 63 minor strokes, with a rate of occurrence of 3.08%. The total number of major strokes was 27, for a rate of 1.32%. There were 28 deaths within a 30-day postprocedure period, resulting in a mortality rate of 1.37%. Restenosis rates of carotid stenting have been 4.80% at 6 mo. Endovascular stent treatment of carotid artery atherosclerotic disease is growing as an alternative to vascular surgery, especially for patients that are at high risk for standard carotid endarterectomy. The periprocedural risks for major and minor strokes and death are generally acceptable at this early stage of development. Cathet. Cardiovasc. Diagn. 44:1–6, 1998.
No takes yet. Share an insight, caveat, or question.
Wholey et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: